top.apis.jpg
Source: Novo Nordisk A/S

Trading in Novo Nordisk shares by board members, executives and associated persons on 5 - 8 February 2020

Bagsværd, Denmark, 10 February 2020 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance with Article 19 of EU Regulation No. 596/2014 on market abuse.

Further information

Media:    
Mette Kruse Danielsen +45 4442 3883 mkd@novonordisk.com
Ken Inchausti (US) +1 609 240 9429 kiau@novonordisk.com
     
Investors:    
Peter Hugreffe Ankersen +45 3075 9085 phak@novonordisk.com
Valdemar Borum Svarrer +45 3079 0301 jvls@novonordisk.com
Ann Søndermølle Rendbæk +45 3075 2253 arnd@novonordisk.com
Mark Joseph Root +45 3079 4211 mjhr@novonordisk.com
Kristoffer Due Berg US) +1 609 235 2989 krdb@novonordisk.com


Attachment